BioSpace News Archive

Carle Health today joined Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five year, multi-million dollar strategic partnership

Interrad Medical, a privately held medical device company, announces a new recommendation for use of SecurAcath on COVID-19 patients.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial results for the first quarter ended March 31, 2020 after the stock market closes on Thursday, May 7, 2020. Hanger’s management team will host a conference call with the financial community to discuss the financial results the following morning on Friday, May 8 at 8

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced positive top-line Phase 1 clinical trial results for ADX-629, a first-in-class orally available reactive aldehyde species (RASP) inhibitor in development for the treatment of systemic i

The EndPandemic National Data Consortium announced today that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which was announced on March 30, 2020.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), the third largest provider of home medical equipment (“HME”) in the United States, today announced the appointment of Andy Palan as its first Chief Technology Officer.

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Shahe Garabedian as Senior Vice President of Quality Assurance and the issuance of an inducement award.

Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets has appointed seasoned medical device sales executive Jeff Weinrich to its Board of Directors

Agilent Technologies, Inc. (NYSE: A) today announced that due to the expanded and evolving nature of the COVID-19 pandemic and resulting effects on customer operations, it is withdrawing its second-quarter and fiscal year 2020 guidance provided on Feb. 18. While Agilent’s fiscal second-quarter revenues grew a